Use of real-time continuous glucose monitoring versus traditional self-monitoring of blood glucose levels improves glycaemic control in patients with type 1 diabetes
- Biobehavioral Health Sciences, University of Illinois, Chicago, Illinois, USA
- Correspondence to Cynthia Fritschi
Biobehavioral Health Sciences, University of Illinois, 845 South Damen M/C 802, Chicago, IL 60612, USA; fritschi{at}uic.edu
Implications for nursing practice and research
-
■ Use of real-time continuous blood glucose monitoring (RT-CGM) as part of treatment of type 1 diabetes results in decreased HbA1c levels when compared with self-monitoring of blood glucose (SMBG).
-
■ The improvement in glycaemic control with RT-CGM use was especially pronounced in patients with poorer glycaemic control and in those who used the technology more frequently.
-
■ Use of RT-CGM may decrease exposure to hypoglycaemia in some patients.
-
■ This model is able to predict cost-effectiveness of RT-CGM in the clinical setting based on glycaemic control, sensor usage and age of patient.
Context
In patients with type 1 diabetes (T1DM), tight glycaemic control is associated with profound reductions in risks for …
